Chemoinformaics analysis of Lupinisoflavone D
| Molecular Weight | 370.357 | nRot | 2 |
| Heavy Atom Molecular Weight | 352.213 | nRig | 22 |
| Exact Molecular Weight | 370.105 | nRing | 4 |
| Solubility: LogS | -3.48 | nHRing | 2 |
| Solubility: LogP | 3.314 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 51.0163 |
| nHD | 4 | BPOL | 22.3977 |
| QED | 0.547 |
| Synth | 3.507 |
| Natural Product Likeliness | 2.354 |
| NR-PPAR-gamma | 0.972 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.108 |
| HIA | 0.014 |
| CACO-2 | -5.074 |
| MDCK | 0.00000778 |
| BBB | 0.011 |
| PPB | 0.978736 |
| VDSS | 0.412 |
| FU | 0.0269436 |
| CYP1A2-inh | 0.73 |
| CYP1A2-sub | 0.244 |
| CYP2c19-inh | 0.181 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.706 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.717 |
| CYP2d6-sub | 0.353 |
| CYP3a4-inh | 0.275 |
| CYP3a4-sub | 0.137 |
| CL | 5.144 |
| T12 | 0.821 |
| hERG | 0.025 |
| Ames | 0.149 |
| ROA | 0.601 |
| SkinSen | 0.875 |
| Carcinogencity | 0.138 |
| EI | 0.475 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.861 |
| Antiviral | Yes |
| Prediction | 0.760198 |